01
Low NADAC$1008.41
→
Avg plan cost$1391.53
Part D spend $4.56B
1× spread, current vs floor
Class summary at a glance.
Every drug in the Interleukin-4 Receptor alpha Antagonist class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $4.56Bcombined across class
- Total Rx claims
- 1.1M203K unique beneficiaries
- Generic mfrs (active)
- 0across all molecules